Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
American chemical industry news
15 May 2026
Technip Energies awarded FNTP for Commonwealth LNG 9.5 Mtpa EPC
FID enables full execution; scope: six identical modular SnapLNG trains to accelerate schedule, reduce costs and improve predictability, advancing modular LNG delivery models.
14 May 2026
Repsol: Refining is strategic for Spain and Europe
Chairman urged removing investment barriers and securing supply amid Iran crisis. CEO forecasts 6–9% DPS growth to 2028, 30–40% of CFO for returns; AGM ok'd dividends, €350m buyback
14 May 2026
OrganOx appoints Naoya Iwata CEO & President
Effective June 1, 2026, he brings 20+ years at Terumo in sales, strategy and business development, including Chief of Staff experience, to scale commercial growth and NMP adoption.
14 May 2026
PureCycle: NJDEP Qualifies PureFive® Resin as Recycled Content
NJDEP grants one-year conditional PCR designation under NJ recycled-content law; firm will seek permanent approval. Resin cleared for food-contact rigid packaging; 10.5M lb NJ feedstock sourced 2025
14 May 2026
Johnson Matthey 2026 PGM Market Report
PGM prices surged; platinum hit record. 2026: deficits likely for platinum, ruthenium, iridium; palladium and rhodium may have small surpluses. Strong prices boost recycling; industrial demand firm.
13 May 2026
Worley wins engineering contract for Orbia's Louisiana LiPF6 plant
Engineering, supply-chain, modularization, construction and automation support for a new large-scale battery electrolyte production facility in the US to bolster battery materials supply.
How does the American chemical industry perform?
Find out with
chemXplore Alpha
Learn more
13 May 2026
Perpetual Next selects Clarksons to broker maritime biomethanol
Chosen broker will market scalable, waste-to-biomethanol via international offtake, finance and logistics for maritime bunkering as demand rises with decarbonization rules.
13 May 2026
Novo Nordisk: Wegovy pill yields 21.6% weight loss in early responders and doubles mobility improvement
Nearly 29% were early responders (≥10% by 16w), averaging 13.2% loss at 16w; non-responders still lost 11.5% by wk64. Overall mean 17% vs 2.7% placebo. Outperformed orforglipron; GI AEs mostly mild.
12 May 2026
Lilly: Foundayo and reduced-dose Zepbound maintain weight loss after switching from high-dose injectables
Two late-phase trials: switching from high-dose injectable incretins to an oral GLP-1 or reducing injectable dose preserved most prior weight loss at 1 year; safety matched prior Phase 3
12 May 2026
TotalEnergies signs MoU with Syrian Petroleum Company for Block 3 offshore exploration
MoU creates a framework for technical review and commercial discussions to assess exploration of offshore Block 3 in Syria's Mediterranean.
12 May 2026
Boehringer Ingelheim licenses Immunitas preclinical antibody program for chronic inflammatory diseases
Global license of a preclinical antibody that targets pathogenic cells at inflammation sites to provide durable control in chronic immune diseases; includes milestones to €407.5M +royalties
12 May 2026
Novo Nordisk: Wegovy cuts weight and reduces cardiovascular and migraine risk across menopausal stages
Trials and real‑world data: semaglutide gave 19.7–22.6% weight loss, 15–17.5% waist reduction, ~42% MACE risk reduction in perimenopause, 42–45% lower migraine and 25% lower depression risk
12 May 2026
Novo Nordisk: Wegovy 7.2 mg yields ~28% weight loss in early responders
STEP UP trial: early responders (≥15% at 24w) sustained major weight loss at 72w; higher dose reached goals faster than 2.4 mg; 84% of lost weight was fat and muscle function preserved.
12 May 2026
DOMO Engineered Materials joins RadiciGroup to create global tier‑1 compounder
Acquisition closed; combined global tier‑1 compounding platform serving diverse end markets. TECHNYL brand and teams remain; CEO appointed; focus on innovation and sustainability.
11 May 2026
GSK partners with Sino Biopharmaceutical (CTTQ) for exclusive China launch of bepirovirsen
Potential first-in-class CHB treatment under priority review in China; deal provides access to 5,000+ medical centres at launch, local import/distribution, hospital access and initial 5.5-yr supply.
11 May 2026
Aurubis reports stronger Q2 and raises full-year forecast
Q2 operating EBT €121m (+15% q/q); H1 EBT €226m; H1 EBITDA €351m (+3%). Net cash flow €161m, down on higher inventories. ROCE 8.1% as €1.7bn projects near completion; new recycling plants ramping up.
8 May 2026
argenx: FDA expands VYVGART/VYVGART Hytrulo approval to all adult gMG patients
Phase-3 ADAPT SERON: VYVGART showed rapid, significant, sustained improvements across anti-MuSK, anti-LRP4 and triple-seronegative gMG; safety consistent; IV/SC options; access support.
8 May 2026
Clariant Q1 2026: Resilient performance amid Middle East conflict
Q1 sales down 2% (CHF918m); EBITDA margin fell to 17.5% (-130bp). Free cash-flow conversion rose to 54%. CHF80m savings program on track; 2026 guidance unchanged amid conflict
7 May 2026
argenx Q1 2026 Financial Results & Business Update
Q1 product sales $1.3B (+63% YoY); profit $366M; PDUFA May 10 for seronegative gMG; VYVGART label expansions, multiple pipeline readouts in 2026–27; cash $4.9B
7 May 2026
Diamond Infrastructure Solutions issues RFQ for Freeport power and steam modernization
RFQ seeks developers to replace two legacy cogeneration plants at Freeport with advanced baseload power and steam facilities (operational ~2032); proposals due June 25, 2026.
7 May 2026
Eni confirms Claudio Descalzi as CEO; appoints board committees
Board affirmed directors' integrity and independence, confirmed Chair's role in internal controls, found auditors and committees compliant, and judged public-shareholder links not to impair independence.
7 May 2026
PureCycle Achieves A3 CosPaTox Rating for Leave‑On Cosmetic‑Grade PureFive Resin
Independent study shows dissolution recycling converts post‑consumer polypropylene into A3 leave‑on cosmetic grade resin commercially, removing contaminants, retaining performance and lowering CO₂
7 May 2026
Roche to acquire PathAI for AI-driven digital pathology
Adds best‑in‑class Image Management System and AI pathology tools to diagnostics, boosting lab automation, companion diagnostics and biomarker discovery. Deal closes H2; $750M + up to $300M
7 May 2026
MAIRE’s Nextchem awarded licensing and PDP for urea-to-DEF plant in Virginia
Licensing & PDP won for a 700 STPD urea melt plant in Virginia, fully integrated to convert all urea to DEF; FID/NTP targeted H1 2027; reflects rising DEF demand from tighter emissions.
6 May 2026
PureCycle Technologies Q1 2026 Results
Ironton turnaround finished early/under budget; record 8.4M lb production (~10M lb feedstock); 5th consecutive revenue growth; two P&G approvals; Q1 net loss $33.4M; liquidity $131M.
6 May 2026
Eli Lilly commits $4.5B to Indiana manufacturing, opens first genetic‑medicine facility
Buildout now totals $21B in Indiana since 2020; upgrades at Lebanon API to produce Foundayo, Zepbound/Mounjaro and retatrutide; project to scale API capacity and boost regional jobs and GDP.
6 May 2026
Topsoe and BioVeritas partner on second‑generation renewable fuels
Deal enables conversion of second-gen feedstocks (woody biomass, corn stover, straw, wastes) into KEYTones for processing with HydroFlex, allowing scalable renewable fuels and SAF in existing plants.
6 May 2026
Delfin Midstream secures 20‑year, 0.3 Mtpa LNG deal with Gunvor
LNG delivered FOB from an FLNG facility 40 nm off Louisiana, using a brownfield deepwater port, UTOS pipeline acquisition and federal approvals to support long-term exports.
6 May 2026
Equinor Q1 2026 results
Adjusted operating income USD 9.77bn; adjusted net income USD 3.70bn. Record production +9% (2,313 mboe/d). Seven NCS discoveries, Raia drilling, Q1 dividend $0.39/sh, $375m buy-back tranche.
6 May 2026
Ørsted Q1 2026: Strong operational performance
EBITDA DKK 9.5bn; offshore generation +27% y/y. First power from Revolution Wind; Sunrise Wind turbines installed; monopiles started at Hornsea 3/Baltica 2. FY EBITDA guidance > DKK28bn
Next →
